Abstract 1329: Preclinical development of EFTX-G12V, a first-in-class EGFR-directed KRAS G12V selective inhibitor.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Lyla J. Stanland, Hayden Huggins, Snehasudha S. Sahoo, Alessandro Porrello, Yogitha Chareddy, Salma Azam, Jillian Perry, Pradeep S. Pallan, Kristina Whately, Lincy Edatt, William D. Green, Matthew C. Fleming, Jonah Im, Christina Gutierrez-Ford, Imani Simmons, Alyaa Dawoud, Katherine I. Zhou, Vandanaa Jayaprakash, Rani Sellers, Gabriela de la Cruz, Albert Wielgus, Justin Milner, Martin Egli, Albert A. Bowers, Chad V. Pecot
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148840780
Cites:
Cited by:
Related to: